Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 1.18

(0.0%)

Revenue Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual revenue in 2023 was 87.26 Million CNY , down -34.06% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly revenue in 2024 Q3 was 19.37 Million CNY , up 76.86% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a annual revenue of 132.34 Million CNY in annual revenue 2022, down -22.83% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a annual revenue of 171.49 Million CNY in annual revenue 2021, down -19.71% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly revenue of 19.37 Million CNY for 2024 Q3, up 76.86% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly revenue of 14.7 Million CNY for 2024 Q1, up 5.06% from previous quarter.

Annual Revenue Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Revenue of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Revenue Revenue Growth
2023 87.26 Million CNY -34.06%
2022 132.34 Million CNY -22.83%
2021 171.49 Million CNY -19.71%
2020 213.58 Million CNY -27.43%
2019 294.32 Million CNY -26.69%
2018 401.48 Million CNY 47.2%
2017 272.73 Million CNY -1.1%
2016 275.76 Million CNY 3.3%
2015 266.96 Million CNY -21.18%
2014 338.68 Million CNY 13.79%
2013 297.64 Million CNY 4.34%
2012 285.26 Million CNY 0.0%

Peer Revenue Comparison of Dali Pharmaceuticalco.,Ltd

Name Revenue Revenue Difference
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 97.182%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 97.001%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 97.703%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 98.979%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 98.207%
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 99.096%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 98.58%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 99.138%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 88.003%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 97.219%
Guobang Pharma Ltd. 5.34 Billion CNY 98.369%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY 79.751%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 95.183%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 98.386%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 97.663%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 98.209%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 95.992%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 99.341%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 95.339%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 98.937%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 99.431%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 98.88%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 99.16%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 98.939%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY 55.663%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 99.641%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY 84.565%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 98.856%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY 86.469%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 89.863%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 92.826%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 98.42%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 92.45%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 97.365%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 99.476%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 99.146%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 99.435%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.884%
China National Medicines Corporation Ltd. 49.69 Billion CNY 99.824%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY 83.08%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 96.858%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY 84.955%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 99.511%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 89.676%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 97.914%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 93.402%
CanSino Biologics Inc. 345.18 Million CNY 74.718%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 99.159%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY 70.105%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 97.983%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 97.218%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 98.044%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY 87.006%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 93.909%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 99.789%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 94.641%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY 87.032%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 95.784%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 97.78%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 90.637%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 99.269%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY 75.775%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 97.181%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 90.518%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 95.986%